Iperparatiroidismo primitivo e Cinacalcet: un caso clinico

Abstract

Get full access to this article

View all access options for this article.

References

Farford

, Presutti

R.J.

, Moraghan

T.J.

Nonsurgical management of primary hyperparathyroidism.

Mayo Clin Proc 2007; 82(3): 351–5.

Peacock

, Bilezikian

J.P.

, Klassen

P.S.

, Guo

M.D.

, Turner

S.A.

, Shoback

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.

J Clin Endocrinol Metab 2005; 90(1 Il calciomimetico nell'iperparatiroidismo primitivo e se): 135–41.

Shoback

D.M.

, Bilezikian

J.P.

, Turner

S.A.

, McCary

L.C.

, Guo

M.D.

, Peacock

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism.

J Clin Endocrinol Metab 2003; 88(12): 5644–9.

Sajid-Crockett

, Singer

F.R.

, Hershman

J.M.

Cinacalcet for the treatment of primary hyperparathyroidism.

Metabolism 2008; 57(4): 517–21.

de Francisco

A.L.

, Piñera

, Palomar

Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3–4 chronic kidney disease.

Nat Clin Pract Nephrol 2008; 4(7): 366–7.

Charytan

, Coburn

J.W.

, Chonchol

. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis 2005; 46(1 Il calciomimetico nell'iperparatiroidismo primitivo e se): 58–67.